Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: A pilot study

Pain

Volumn 83, Issue 3, 1999, Pages 631-635

  Yuan, C S ^a   Foss, J F ^a   O'Connor, M ^a   Osinski, J ^a   Roizen, M F ^a   Moss, J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Constipation; Laxation; Methadone; Methylnaltrexone; Opioid; Oral cecal transit time

Indexed keywords

17 METHYLNALTREXONE; METHADONE;

ABDOMINAL CRAMP; ADULT; ARTICLE; CASE REPORT; CONSTIPATION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHADONE TREATMENT; PRIORITY JOURNAL;

ADULT; ANALGESICS, OPIOID; CONSTIPATION; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; MALE; METHADONE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; QUATERNARY AMMONIUM COMPOUNDS;

EID: 0032752321     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00162-1     Document Type: Article

References (21)

1. Basilisco G., Camboni G., Bozzani A., Paravicini M., Bianchi P.A. Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci. 32:1987;829-832.
2. 2) measurements. J Lab Clin Med. 85:1975;546-555.
3. Brown D.R., Goldberg L.I. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 24:1985;181-191.
4. Cameron J.C. Constipation related to narcotic therapy: a protocol for nurses and patients. Cancer Nurs. 15:1992;372-377.
5. Culpepper-Morgan J.A., Inturrisi C.E., Portenoy R.K., Foley K., Houde W.R., Marsh F., Kreek M.J. Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther. 52:1992;90-95.
6. Foss J.F., O'Connor M., Yuan C.S., Murphy M., Moss J., Roizen M.F. Safety and tolerance of methylnaltrexone in healthy humans: a randomized placebo-controlled intravenous ascending-dose and pharmacokinetic study. J Clin Pharmacol. 37:1997;25-30.
7. Fraser H.F., Van Horn G.D., Martin W.R., Wolbach A.B., Isbell H. Methods for evaluating addiction liability.(A) 'Attitude' of opiate addicts toward opiate-like drugs, (B) A short-term 'direct' addiction test. J Pharmacol Exp Ther. 133:1961;371-387.
8. Glare P., Lickiss J.N. Unrecognized constipation in patients with advanced cancer: a recipe for therapeutic disaster. J Pain Symptom Manage. 7:1992;369-371.
9. Gowan J.D., Hurtig J.B., Fraser R.A., Torbicki E., Kitts J. Naloxone infusion after prophylactic epidural morphine: effects on incidence of postoperative side-effects and quality of analgesia. Can J Anaesth. 35:1988;143-148.
10. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. Gilman A.F., Rall T.W., Nies A.S., Taylor P. The pharmacological basis of therapeutics. 1990;485-521 Pergamon Press, New York.
11. Jasinski D.R. Assessment of the abuse potentiality of morphine-like drugs (method used in man). Martin W.R. Drug Addiction 1. 1977;197-258 Springer-Verlag, New York.
12. Kim C., Cheng R., Corrigall W.A., Coen K.M. Assay for methylnaltrexone in rat brain regions and serum by high-performance liquid chromatography with coulometric electrochemical detection. Chromatographia. 28:1989;359-363.
13. McCaffrey M., Beebe A. Managing your patients' adverse reactions to narcotics. Nursing. 19:1989;166-168.
14. Meier D.E., Morrison R.S., Cassel C.K. Improving palliative care. Ann Intern Med. 127:1997;225-230.
15. O'Keefe E.A., Talley N.J., Zinsmeister A.R., Jacobsen S.J. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol. 50:1995;184-189.
16. Parup P.G., Hovdenak S., Wetterhus S., Lange O.J., Hovde O., Trondstak R. The symptomatic effect of disapride in patients with irritable bowel syndrome and constipation. Scand J Gastroenterol. 33:1998;128-131.
17. Read N.W., Al-Janabi M.N., Bates T.E., Holgate A.M., Cann P.A., Kansman R.I., McFarlane A., Brown C. Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate. Gut. 26:1985;834-842.
18. Russel J., Bass P., Goldberg L.I., Schuster C.R., Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol. 78:1982;255-261.
19. Walsh T.D. Oral morphine in chronic cancer pain. Pain. 18:1984;1-11.
20. Yuan C.S., Foss J.F., O'Connor M., Toledano A., Roizen M.F., Moss J. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther. 59:1996;469-475.
21. Yuan C.S., Foss J.F., Moss J., Roizen M.F. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol. 38:1998;931-935.